Psychopharmacology for Pediatr. Cet article n’est pas disponible.Psychopharmacology for Pediatr

This innovative new resource provides a game-changing new approach in managing the complicated issues surrounding prescribing and monitoring psychopharmacological medications in children and teens.

The new concept involves creating different levels of drugs. Level 1 drugs can be confidently prescribed by primary care physicians, and the book gives guidance on starting, dosing, monitoring, and managing adverse reactions.  Level 2 drugs are to be prescribed only by psychiatrists or those practicing paediatricians who have experience and comfort doing so.  The book provides guidance for primary care physicians on monitoring specific Level 2 medications their patients may be taking.

It also provides resources on clinical assessment, preparation, and conceptual framework for prescribing; what to do if the medication isn't working; and managing multiple medications.

The compact reference book will be accompanied by a digital tool allowing the physician to quickly access information on specific conditions and medications.

Mark A. Riddle, M.D. is Professor of Psychiatry and Pediatrics and former Director of the Division of Child and Adolescent Psychiatry at the Johns Hopkins University School of Medicine. His research, teaching and clinical practice focuses on pediatric psychopharmacology, particularly the efficacy and safety of psychotropic medications in children and adolescents. Dr. Riddle serves as a member of the National Institute of Child Health and Human Development-sponsored Data and Safety Monitoring Board for the Best Pharmaceuticals for Children Act. His clinical research and publications include pivotal studies of all of the major groups of medications prescribed to treat psychiatric disorders in children and adolescents.